ArticleJournal of Cancer2020

EphB2 represents an independent prognostic marker in patients with gastric cancer and promotes tumour cell aggressiveness.

Jie Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.